🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is aimed at assessing the safety and immunogenicity of HCV prime-...
Status
Completed
Location
Centre for Cinical Vaccinology and Tropical Medicine, Univeristy of Oxford
Start Date
2017-12-04
Trial ID
NCT03688061
Treatments Being Tested
This study is a multi-center, double-blind, placebo-controlled, Phase I stu...
Status
Completed
Location
University of Iowa - Vaccine Research and Education Unit
Start Date
2016-07-05
Trial ID
NCT02743455
Treatments Being Tested
This randomized clinical trial (RCT) evaluates whether metformin can reduce...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-04-07
Trial ID
NCT06829238
This Phase 2 study aims to improve preparedness for future Ebola outbreaks ...
Status
Completed
Location
Hôpital Général de Référence de Boende
Start Date
2019-12-18
Trial ID
NCT04186000
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
RATIONALE: Vaccines made from a gene-modified virus may help the body build...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00227474
The purpose of this trial is to assess the effectiveness of TroVax® compare...
Status
Completed
Location
Leeds Teaching Hospitals NHS Trust
Start Date
2013-11
Trial ID
NCT01556841
This is a dual arm, open label phase I/II study to evaluate the safety and ...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center
Start Date
2018-08-08
Trial ID
NCT03376659
Treatments Being Tested
This is a multi-center Phase II randomized study. We plan to enroll 78 pati...
Status
Terminated
Location
City of Hope
Start Date
2018-06-26
Trial ID
NCT03547999
Treatments Being Tested